6-K ·Filed Oct 21, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Routine conference attendance announcement with no new data or catalysts. Monitor for any future clinical trial updates or partnership announcements that may emerge from the conference.
Latest settled — T+1d
TLSA ▼ -0.99% at T+1d
NEUTRAL call -0.99% · α vs SPY +0.19% · entry $1.01 → $1.00
Latest observation: T+2 -2.09% FF3 residual α
T+1d
-0.99%
call -0.99% · α +0.19%
$1.00
settled 4d ago
T+5d
Pending
tomorrow
T+20d
Pending
in 23d
T+60d
Pending
in 3mo
Price Chart
Loading chart...
Executive Summary
Tiziana Life Sciences announced that management will attend the joint ACTRIMS-ECTRIMS meeting (MSToronto2026) in Toronto from October 21-23, 2026. This is a routine conference attendance announcement with no material financial or clinical data disclosed.
Key Facts
- Management and business development team attending MSToronto2026, October 21-23, 2026
- Company representatives available to discuss INFORM-MS trial (NCT06292923) of intranasal foralumab in na-SPMS
- Ongoing studies in Alzheimer's disease, multiple system atrophy (MSA), and amyotrophic lateral sclerosis (ALS) mentioned
- No new clinical data, financial results, or material agreements announced
Financial Impact
No financial impact disclosed
Risk Factors
- No material information provided that would move the stock
- Conference attendance alone does not indicate imminent clinical or regulatory milestones
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-111173 |
| Document: ea030914101ex99-1.htm | 0001213900-26-111173 |
| Document: 0001213900-26-111173-index-headers.html | 0001213900-26-111173 |
| Document: 0001213900-26-111173-index.html | 0001213900-26-111173 |
| Document: 0001213900-26-111173.txt | 0001213900-26-111173 |
25 reports for TLSA
54% Hit rate @ T+20 Went positive at some point 13 of 15 best @ T+20▲ +19.82%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 6-K | $1.01 | awaiting T+20 | — | $0.8907 (−11.81%) |
Oct 16, 2026 9d ago | 6-K | $1.01 | awaiting T+20 | — | $0.8907 (+11.81%) |
Oct 16, 2026 10d ago | 6-K | $1.05 | awaiting T+20 | — | $0.8907 (−15.17%) |
Sep 30, 2026 26d ago | 6-K | $1.11 | awaiting T+20 | — | $0.8907 (−19.76%) |
Sep 28, 2026 28d ago | 6-K | $0.9800 | awaiting T+20 | — | $0.8907 (−9.11%) |
Sep 21, 2026 5w ago | 6-K | $0.9046 $1.01 | ▲ +11.65% | ▲ +12.56% | $0.8907 (−1.54%) |
Sep 17, 2026 5w ago | 6-K | $0.9700 $1.05 | ▲ +8.25% | ▲ +7.04% | $0.8907 (−8.18%) |
Sep 17, 2026 5w ago | Press Release | $0.9700 $1.05 | ▲ +8.25% | ▲ +7.04% | $0.8907 (−8.18%) |
Aug 24, 2026 9w ago | 6-K | $1.15 $0.8899 | ▼ −22.62% | ▼ −23.93% | $0.8907 (−22.55%) |
Aug 6, 2026 11w ago | 6-K | $0.9700 $0.9745 | ▲ +0.46% | ▼ −0.14% | $0.8907 (−8.18%) |
Showing 10 of 25
US Market Status
Market Open — Closes in 4h 42m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers